Skip to main content

Table 2 Baseline characteristics of patients

From: Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol

Characteristic

Value

Male (n [%])

34 (68%)

Age (years; median [IQR])

66 (54 to 73)

BMI (median [IQR])a

25.5 (22.3 to 29.1)

Underweight (BMI <18.5 kg/m2; n [%])

4 (8%)

Overweight but not obese (BMI 25 to 30 kg/m2; n [%])

19 (38%)

Obese (BMI >30 kg/m2; n [%])

6 (12%)

Patients taking drugs influencing glycaemia (n [%])b

36 (72%)

Parenteral nutrition for all or part of admission (n [%])

9 (18%)

Enteral nutrition for all or part of admission (n [%])

43 (86%)

Glucose 50% infusion for all or part of admission (n [%])

42 (84%)

APACHE II score (first 24 hours; median [IQR])c

23 (17–29)

SAPS II score (first 24 hours; median [IQR])d

47 (35–64)

History of diabetes (n [%])

6 (12%)

Treated with insulin (n [%])

1 (2%)

Treated with oral agents (n [%])

4 (8%)

Diet controlled (n [%])

2 (4%)

  1. Fifty patients were included in the study. aBody mass index (BMI) calculated as weight (kg) divided by height (metres) squared. bSee Table 1 for a list of commonly used drugs known to affect glycaemia. cAcute Physiology and Chronic Health Evaluation (APACHE) II score range 0 to 71. dSimplified Acute Physiology Score (SAPS)II range 31 to 163. IQR, interquartile range.